MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/16/2026, 02:49 AM (Berlin time), refresh in progress.

Fresenius Stock

Fresenius SE & Co. KGaA

FRE.DEXETRARadar
€43.86
+0.7% today

Company data

Sector
Healthcare
Industry
Medical - Care Facilities
Country
Germany
CEO
Michael Sen
Employees
178,486
Market cap
€24.7 B
IPO
09/11/1998

Fresenius SE & Co. KGaA is a diverse healthcare enterprise headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912, the company provides a comprehensive array of products and services primarily focused on dialysis, hospital management, and outpatient medical care. The business activities are structured…

Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.

Fresenius stock: price history

15/10/25-7.7 %15/10/26

1D

+0.7%

1W

+5.5%

1M

-3.4%

6M

-0.7%

YTD

-10.5%

1Y

-7.7%

2Y

+30.0%

5Y

+7.2%

10Y

-37.2%

Next earnings date

Next earnings date

04/11/2026 (in 18 days)

Volatility around earnings

~26% stronger price swings than usual

Fresenius stock scores

  • Valuation

    Visible after free registration

  • Trend

    Visible after free registration

  • Quality

    Visible after free registration

  • Dividend

    Visible after free registration

  • Growth

    Visible after free registration

  • Insider

    Visible after free registration

  • Earnings

    Visible after free registration

  • Revisions

    Visible after free registration

  • Sentiment

    Visible after free registration

  • Short Pressure

    Visible after free registration

Register for free

Unlock all 11 scores

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.

Ask the agents about Fresenius

Analyst assessment of Fresenius

0

STRONG BUY

1

BUY

0

HOLD

0

SELL

0

STRONG SELL

1

TOTAL · Buy

As of: 02/01/2023

ANALYST FIRMRATINGACTIONDATE
JefferiesHold → Buyupgrade02/01/2023 (older than 12 months)

Fresenius stock metrics

P/E

15.95

P/B

1.25

EV/EBITDA

9.57

RETURN ON EQUITY

1.9%

NET MARGIN

6.4%

DEBT/EQUITY

0.58

DIVIDEND YIELD

2.4%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

72.9%

FLOAT SHARES

410,560,548

AVG. DAILY VOLUME (30D)

1,153,574

Dividends & Stock splits

Dividends

EX-DATEPAY DATEAMOUNTYIELD
25/05/202627/05/2026€1.052.7 %
26/05/202528/05/2025€1.002.3 %
18/05/202323/05/2023€0.923.4 %
16/05/202213/06/2022€0.922.8 %
24/05/202127/05/2021€0.882 %
Page 1 / 6

Stock splits

DATERATIO
04/08/20143:1
02/02/20073:1
17/11/200541:40

Comparable stocks

Frequently asked questions about Fresenius stock

What does Fresenius do?

Fresenius SE & Co. KGaA is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in Germany.

The CEO is Michael Sen, the company employs around 178,486 people.

The IPO was on 09/11/1998; the stock trades on XETRA under the ticker FRE.DE.

What do analysts say about Fresenius stock?

1 analysts rate the stock, the consensus is Buy (as of 02/01/2023).

This is an external assessment, not a statement by Market Jury.

When does Fresenius report next?

The next earnings date is 04/11/2026.

Around past earnings, price swings were roughly 26% stronger than usual.

Does Fresenius pay a dividend?

Yes. The last dividend was €1.05 per share, ex-date 25/05/2026, paid on 27/05/2026.

The dividend yield is 2.4% (as of 30/06/2026).

Which stocks are comparable to Fresenius?

Comparable stocks include Fresenius Medical Care, HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group and Concentra Group Holdings Parent.

How can I get Fresenius stock analyzed?

Clicking "Analyze stock" lets five strategies assess Fresenius against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.